» Articles » PMID: 21442165

Relationship Between Arterial Dysfunction and Extra-articular Features in Patients with Rheumatoid Arthritis

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2011 Mar 29
PMID 21442165
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic inflammation may be a common process that underpins both atherosclerosis and extra-articular features (ExRA) of rheumatoid arthritis (RA). We evaluated the relationship between ExRA and arterial dysfunction in 114 consecutive patients with RA (82% women) without overt arterial disease aged 40-65 years. A trained research nurse undertook 'SphygmoCor' pulse wave analysis (PWA) using radial applanation tonometry to measure the extent (augmentation index, AIX%) and timing (reflected wave transit time, RWT, msec) of aortic wave reflection. Assessment included fasting blood sample, patient questionnaire and medical record review. Mean differences were adjusted for age, sex, mean blood pressure, smoking pack-years, fasting cholesterol, Stanford HAQ score and erythrocyte sedimentation rate. Mean age was 54 (SD 7) and median RA duration 10 (IQR 4-17) years. There was a trend for arterial dysfunction (higher AIX%; lower RWT) to increase as the number of ExRA features rose, but no difference in AIX% (-0.5, 95%CI -2.8 to 1.8, P = 0.65) or RWT (0.3 ms, 95%CI -3.6 to 4.2, P = 0.86) between 'any ExRA' and 'no ExRA'. Arterial dysfunction was not associated with the presence of rheumatoid nodules, Sjogren's syndrome or carpal tunnel syndrome. Our study was too small to determine whether severe ('Malmo') ExRA (vasculitis, pericarditis, episcleritis) was truly associated with a higher AIX% (3.8, 95%CI -2.3 to 9.9, P = 0.22) and lower RWT (-5.5 ms 95%CI -13.1 to 2.1, P = 0.16). While arterial dysfunction may be associated with the number of ExRA features and severe ExRA, it does not appear to be associated with other ExRA features.

Citing Articles

Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study.

Kimbrough B, Crowson C, Davis 3rd J, Matteson E, Myasoedova E Arthritis Care Res (Hoboken). 2023; 76(4):454-462.

PMID: 37691141 PMC: 10924769. DOI: 10.1002/acr.25231.

References
1.
Turesson C, Jacobsson L, Bergstrom U . Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999; 38(7):668-74. DOI: 10.1093/rheumatology/38.7.668. View

2.
Mackenzie I, Wilkinson I, Cockcroft J . Assessment of arterial stiffness in clinical practice. QJM. 2002; 95(2):67-74. DOI: 10.1093/qjmed/95.2.67. View

3.
Maki-Petaja K, Booth A, Hall F, Wallace S, Brown J, Mceniery C . Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007; 50(9):852-8. DOI: 10.1016/j.jacc.2007.04.076. View

4.
Turesson C, OFallon W, Crowson C, Gabriel S, Matteson E . Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol. 2002; 29(1):62-7. View

5.
Turesson C, McClelland R, Christianson T, Matteson E . Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2006; 66(1):70-5. PMC: 1798415. DOI: 10.1136/ard.2006.052506. View